PSMA PET/CT in Prostate Cancer: Next-Level Precision at Healthcare International
Introduction At Healthcare International , we offer world-class PSMA PET/CT imaging—an advanced modality that elevates diagnostic accuracy for prostate cancer . By combining molecular targeting with high-resolution imaging, PSMA PET/CT enables early detection, precise treatment planning, and improved outcomes—while preserving quality of life. 1. Why PSMA PET/CT is a Game-Changer Targeted detection of prostate cancer , even at very low PSA levels—well beyond the capability of traditional imaging. Detects pelvic lymph node metastases with ~85% sensitivity (compared to ~38% via conventional bone scans and CT). In high-risk cases, early identification of hidden metastases occurred in 28% of patients, significantly altering treatment strategies. Plays a key role in radiation therapy planning, enabling accurate targeting for IGRT, SBRT, CyberKnife, and Proton Beam Therapy (PBT). 2. Impact on Treatment Decisions PSMA...
